NO934653D0 - Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse - Google Patents

Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Info

Publication number
NO934653D0
NO934653D0 NO934653D NO934653D NO934653D0 NO 934653 D0 NO934653 D0 NO 934653D0 NO 934653 D NO934653 D NO 934653D NO 934653 D NO934653 D NO 934653D NO 934653 D0 NO934653 D0 NO 934653D0
Authority
NO
Norway
Prior art keywords
inhibition
thrombin inhibitors
fibrin formation
ocular
ocular fibrin
Prior art date
Application number
NO934653D
Other languages
English (en)
Inventor
Juergen Roemisch
Eric Paul Paques
Eckhard Schueler
Original Assignee
Behringswerke Aktiengeschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringswerke Aktiengeschaft filed Critical Behringswerke Aktiengeschaft
Publication of NO934653D0 publication Critical patent/NO934653D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO934653D 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse NO934653D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4242655A DE4242655A1 (de) 1992-12-17 1992-12-17 Verwendung von Thrombin-Inhibitoren zur Inhibition okularer Fibrinbildung

Publications (1)

Publication Number Publication Date
NO934653D0 true NO934653D0 (no) 1993-12-16

Family

ID=6475561

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934653A NO934653L (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
NO934653D NO934653D0 (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO934653A NO934653L (no) 1992-12-17 1993-12-16 Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse

Country Status (7)

Country Link
EP (1) EP0603112A1 (no)
JP (1) JPH06228006A (no)
KR (1) KR940013532A (no)
AU (1) AU675090B2 (no)
CA (1) CA2111644A1 (no)
DE (1) DE4242655A1 (no)
NO (2) NO934653L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
CA2404115A1 (en) * 2000-03-20 2001-09-27 Knoll Gmbh The use of peg-hirudin as an anticoagulant agent in the extracorporeal treatment of blood
WO2002050056A1 (en) 2000-12-18 2002-06-27 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
WO2002064559A2 (en) 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203887D0 (sv) * 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
NL8902454A (nl) * 1989-10-03 1991-05-01 Stichting Centraal Lab Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten.
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
DE4111394A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Also Published As

Publication number Publication date
JPH06228006A (ja) 1994-08-16
NO934653L (no) 1994-06-20
KR940013532A (ko) 1994-07-15
AU5243693A (en) 1994-06-30
CA2111644A1 (en) 1994-06-18
AU675090B2 (en) 1997-01-23
EP0603112A1 (de) 1994-06-22
DE4242655A1 (de) 1994-06-23

Similar Documents

Publication Publication Date Title
FI951059A (fi) HIV-aspartyyliproteaasin sulfonamidi-inhibiittoreita
NO982809L (no) Prolegemidler av tombin-inhibitorer
NO974722D0 (no) THF-inneholdende sulfonamidhemmere av aspartylprotease
NO974744D0 (no) Oksygenert-heterocykelinneholdende sulfonamidhemmere av aspartylprotease
NO960723D0 (no) Inhibitorer for TNF-alfa-sekresjon
ZA939285B (en) Inhibitors of aspartyl protease
LV12102A (lv) Rotamazes funkciju inhibitori
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
NO20003332D0 (no) Midisinforløper av aspartylproteaseinhibitorer
FI941519A0 (fi) Farnesyyliproteiinitransferaasin heterosyklisiä inhibiittoreita
FI964137A (fi) Rotamaasi-entsyymiaktiivisuuden inhibiittoreita
EE04241B1 (et) Apolipoproteiin-B sünteesi inhibiitorid
AU2251892A (en) Inhibitors of picornavirus proteases
NO934653D0 (no) Anvendelse av trombininhibitorer for inhibitering av okkular fibrindannelse
NO934721D0 (no) Hemmere av HIV-protease som er nyttige for behandling av AIDS
FI925144A (fi) Anvaendning av inhibitorer foer faergutvecklingen i kromogena bestaemningar
NO940190L (no) Anvendelse av alpha-ketoglutarat
NO953272D0 (no) Kombinasjoner av retrovirale inhibitorer
GB9208596D0 (en) Inhibitors of thrombin
NO931629D0 (no) Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi
NO922191D0 (no) Nye thrombininhibitorer
NO914562D0 (no) Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft
NO920025L (no) Synergime av hiv-reverstranskriptaseinhibitorer
NO940997D0 (no) Guanidinyl-substituerte heterocykliske trombin-inhibitorer
ZA938470B (en) Sulfonamide inhibitors of aspartyl protease